Business Wire

Exasol dominates its peer groups in BARC Data Management Survey 2020

24.9.2020 11:15:00 EEST | Business Wire | Press release

Share

Exasol, the high-performance analytics database, achieved 18 top-rankings and 4 leading positions in its two peer groups in The Data Management Survey 20. In addition, 100 percent of Exasol users chose the Exasol database because of its convincing performance and would recommend it to others. The survey was conducted by BARC (Business Application Research Center), Europe’s leading analyst firms for business software based in Würzburg, Germany.

“Exasol achieved truly remarkable results in the Data Management Survey 2020 with 18 top rankings,” said Timm Grosser, Senior Analyst Data & Analytics at BARC and author of the study. “Users gave Exasol the highest possible score for two crucial criteria when it comes to data platforms: 'performance' and 'platform reliability'. In today’s world, users need reliable and fast data for their operational and analytical processes. Similarly, the stability and performance of a data platform, even under pressure and high demand, are business-critical. Exasol has ranked impressively well in all the key areas and 100 percent of users surveyed in the Data Management Survey would recommend its high-performance analytics database to others.”

In the survey, twelve products were grouped into six peer groups to make them more comparable. The Exasol database was evaluated in both the Analytical Database Products peer group and the Data Warehouse Technologies peer group using twelve KPIs determined by BARC research. In both peer groups, the Exasol database was ranked top in the following categories:

  • Time to market;
  • Innovation power;
  • Performance;
  • Platform reliability;
  • Support quality;
  • Breadth of supported use cases;
  • Product satisfaction;
  • Recommendation.

In the group of Analytical Database Products, Exasol also achieved the top positions for Price-to-value and Functionality.

Exasol was ranked as a leader—among the top 25 to 30 percent of the products in the group—in the Developer Efficiency category in both peer groups, and in the data warehouse technologies peer group in the Price-to-value and Functionality categories.

“We are proud of our top rankings in BARC’s The Data Management Survey 2020. These excellent results show the high satisfaction of our customers,” said Aaron Auld, CEO of Exasol. “The fact that we scored ten out of ten in each of the two peer groups in the categories for Recommendation, Platform Reliability and Performance proves that we not only have the most powerful database for analytical workloads, but that we are committed to ensuring that our platform enables our customers to make data-driven decisions based on the most up-to-date data every day.”

The survey also shows that 93 percent of Exasol users use the database for data warehousing and business intelligence (BI) and 69 percent for data integration. Download the report, which includes a detailed overview of Exasol’s highlight results in BARC’S The Data Management Survey 2020.

###

About The Data Management Survey
The Data Management Survey 20 was conducted by BARC from December 2019 to March 2020. Altogether, 634 respondents worldwide answered a series of questions about their data management software. The survey offers a comparison of 12 leading data management tools across 12 criteria (KPIs) including developer efficiency, recommendation, time to market and product satisfaction. For more information, go to www.bi-survey.com.“

About Exasol
The Exasol high-performance analytics database is built to run faster than any other database, delivering next-level performance, scale and ease of use. Analyze billions of rows in seconds; run high-performance analytics securely in the cloud or on-premise; deliver frictionless analytics with self-indexing that automatically tunes performance; and scale out analytics for one transparent price. To learn more, please visit: www.exasol.com

###

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PR Contacts:
Carla Gutierrez, Global Head of Communications at Exasol
Email: Carla.gutierrez@exasol.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns7.7.2026 08:00:00 EEST | Press release

Galderma (SWX:GALD) has unveiled results from the world’s most extensive skin quality profiling survey, finding that skin quality concerns are widespread, can impact emotional wellbeing and, while differing based on the individual, are often similar among people alike in age, lifestyle, and environment.1 These results underscore the need for effective solutions that can be tailored to a wide variety of skin quality concerns. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706426842/en/ Key findings:1 Nine out of ten people globally are affected by skin quality concerns, with each person experiencing an average of two concerns in the past month The most common concerns are fine lines and wrinkles (41%), dry skin (40%), and dull skin (37%), most frequently affecting the face Skin quality impacts quality of life for 85% of people, with more than one in three reporting feelings of self-consciousness, insecurity or anxiety Skin

Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient7.7.2026 05:00:00 EEST | Press release

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/ Growing Interest in Postbiotics and Mental Well-Being Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing awareness of the connection between the gut and the brain, commonly referred to as the gut–brain axis. As a result, the g

Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 03:00:00 EEST | Press release

Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera

Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 02:00:00 EEST | Press release

Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Kath Harrison, Group President, International Growth at Real Chemistry. “By bringing Spurwing into Real Chemistry,

Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 23:04:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired. The transaction was unanimously approved by both the Vertex and Crinetics Boards of Directors and is anticipated to close in the third quarter of 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706876183/en/ Crinetics’ marketed medicine, PALSONIFY® (paltusotine), received approval from the U.S. Food and Drug Administration (FDA) in September 2025. PALSONIFY was recently approved by the European Medicines Agency (EMA) a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye